Market Place
Sourcing Support
RS BioTherapeutics Announces Collaboration With University Of Colorado
08 Jul 2024 //
GLOBENEWSWIRE
RS BioTherapeutics Launches Crowdfunding Campaign Through StartEngine
30 Apr 2024 //
GLOBENEWSWIRE
RS Bio Adds Jane Wright-Mitchell to Advisory Board
25 Apr 2024 //
GLOBENEWSWIRE
RS BioTherapeutics Selected for Presentation at American Thoracic 2024
18 Mar 2024 //
GLOBENEWSWIRE
RS BioTherapeutics Selected for Presentation at ATS
18 Mar 2024 //
GLOBENEWSWIRE
RS BioTherapeutics Creates Therapeutic Expert Council
21 Feb 2024 //
GLOBENEWSWIRE
RS BioTherapeutics Promotes Michelle L. Shuffett, MD to Chief Medical Officer
31 Oct 2023 //
GLOBENEWSWIRE
RS BioTherapeutics and NIH Execute Research Collaboration Agreement
29 Aug 2023 //
GLOBENEWSWIRE
RS BioTherapeutics Appoints Michelle L. Shuffett, MD as SVP of Medical Affairs
05 Jun 2023 //
GLOBENEWSWIRE
RS BioTherapeutics Joins BioNTX & Healthcare Innovation Trade Organization
15 May 2023 //
GLOBENEWSWIRE
RS BioTherapeutics Announces Filing of Provisional Plant Patent Application
01 May 2023 //
GLOBENEWSWIRE
RS BioTherapeutics Appoints Pharmaceutical & Consumer Products Veteran Curtis R
17 Apr 2023 //
GLOBENEWSWIRE
RS Bio Appoints Industry Veteran Dean Hart as Chief Executive Officer
10 Apr 2023 //
GLOBENEWSWIRE
RS Partners with Recipharm to Conduct Product Characterization for RSBT-001
17 Nov 2022 //
CONTRACTPHARMA
RS BioTherapeutics Selects Recipharm as Product Characterization Partner
14 Nov 2022 //
GLOBENEWSWIRE
RS BioTherapeutics Secures $3 Million Seed II Round of Funding
26 Sep 2022 //
GLOBENEWSWIRE
RS Biotherapeutics Appoints Jeremy Plumb as Chief Cultivation Officer
01 Aug 2022 //
GLOBENEWSWIRE
RS Biotherapeutics Reports Positive Results From Proof-of-Concept Trial
11 Jul 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.